AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
-0.1%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$210M
AUM Growth
+$210M
Cap. Flow
+$13.3M
Cap. Flow %
6.34%
Top 10 Hldgs %
53.68%
Holding
85
New
10
Increased
25
Reduced
14
Closed
11

Top Buys

1
PTGX icon
Protagonist Therapeutics
PTGX
$4.04M
2
VINC
Vincerx Pharma, Inc. Common Stock
VINC
$3.84M
3
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$3.45M
4
NARI
Inari Medical, Inc. Common Stock
NARI
$3.26M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
$2.94M

Top Sells

1
TVTX icon
Travere Therapeutics
TVTX
$5.49M
2
MSACU
Medicus Sciences Acquisition Corp. Unit
MSACU
$2.96M
3
CRIS icon
Curis
CRIS
$2.82M
4
CLDX icon
Celldex Therapeutics
CLDX
$2.68M
5
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
$2.5M

Sector Composition

1 Healthcare 90.08%
2 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MREO
26
Mereo BioPharma
MREO
$275M
$2.06M 0.74%
650,000
-250,000
-28% -$793K
SWTX
27
DELISTED
SpringWorks Therapeutics
SWTX
$2.06M 0.74%
25,000
-2,000
-7% -$165K
EPIX icon
28
ESSA Pharma
EPIX
$11.2M
$2M 0.72%
70,000
-20,000
-22% -$571K
SDGR icon
29
Schrodinger
SDGR
$1.42B
$1.89M 0.68%
+25,000
New +$1.89M
ESTA icon
30
Establishment Labs
ESTA
$1.11B
$1.75M 0.63%
20,000
+10,000
+100% +$874K
AXSM icon
31
Axsome Therapeutics
AXSM
$6.09B
$1.69M 0.6%
25,000
+15,000
+150% +$1.01M
CLDX icon
32
Celldex Therapeutics
CLDX
$1.57B
$1.67M 0.6%
50,000
-80,000
-62% -$2.68M
NTLA icon
33
Intellia Therapeutics
NTLA
$1.26B
$1.62M 0.58%
+10,000
New +$1.62M
SNCE
34
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.5M 0.54%
150,000
-250,000
-63% -$2.5M
CNTA
35
Centessa Pharmaceuticals
CNTA
$2.13B
$1.49M 0.53%
+66,957
New +$1.49M
BFLY icon
36
Butterfly Network
BFLY
$378M
$1.45M 0.52%
100,000
– –
GLPG icon
37
Galapagos
GLPG
$2.06B
$1.39M 0.5%
20,000
+7,500
+60% +$520K
CYTK icon
38
Cytokinetics
CYTK
$5.98B
$1.39M 0.5%
70,000
+30,000
+75% +$594K
AFIB
39
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
$1.36M 0.49%
80,000
+20,000
+33% +$340K
KALV icon
40
KalVista Pharmaceuticals
KALV
$713M
$1.2M 0.43%
50,000
-50,000
-50% -$1.2M
CGEM icon
41
Cullinan Oncology
CGEM
$456M
$1.16M 0.41%
+45,000
New +$1.16M
MRSN icon
42
Mersana Therapeutics
MRSN
$34.8M
$1.15M 0.41%
85,000
– –
TNGX icon
43
Tango Therapeutics
TNGX
$745M
$1.14M 0.41%
100,000
– –
PCVX icon
44
Vaxcyte
PCVX
$4.17B
$1.13M 0.4%
50,000
+20,000
+67% +$450K
CEREW
45
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$1.04M 0.37%
72,466
– –
ZYME icon
46
Zymeworks
ZYME
$1.07B
$1.04M 0.37%
30,000
-50,000
-63% -$1.74M
NSTG
47
DELISTED
NanoString Technologies, Inc.
NSTG
$972K 0.35%
+15,000
New +$972K
BLU
48
DELISTED
BELLUS Health Inc.
BLU
$933K 0.33%
300,000
– –
QSI icon
49
Quantum-Si Incorporated
QSI
$217M
$920K 0.33%
75,000
-75,000
-50% -$920K
CHAQ.U
50
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$819K 0.29%
75,000
– –
1
2
3 4